
A prophylactic vaccine is required to achieve the World Health Organization’s objective for hepatitis C virus elimination as a serious public health threat. However, the lack of robust immunocompetent animal models supporting hepatitis C virus infection impedes vaccine development as well as studies of immune responses and viral evasion.
CD36 Antigens, Mice, Disease Models, Animal, Immunocompromised Host, Mutation, Animals, Hepacivirus, Viremia, Adaptation, Physiological, Hepatitis C, Rats, Cell Line
CD36 Antigens, Mice, Disease Models, Animal, Immunocompromised Host, Mutation, Animals, Hepacivirus, Viremia, Adaptation, Physiological, Hepatitis C, Rats, Cell Line
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 10 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
